MoneyWorks4Me

Venus Remedies informs about clarification of price movement

06 Jan 2021 Evaluate
Venus Remedies has informed that the company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 from time to time and has not withheld any material information that in its opinion would have a bearing on the price/ volume behavior in the company's script. The said significant movement in the share price is purely market driven.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..